AAAAAA
Results: 1-25/30
Authors:
Ripamonti, C
Fulfaro, F
Citation: C. Ripamonti et F. Fulfaro, Pathogenesis and pharmacological treatment of bone pain in skeletal metastases, Q J NUCL M, 45(1), 2001, pp. 65-77
Authors:
Ripamonti, C
Twycross, R
Baines, M
Bozzetti, F
Capri, S
De Conno, F
Gemlo, B
Hunt, TM
Krebs, HB
Mercadante, S
Schaerer, R
Wilkinson, P
Citation: C. Ripamonti et al., Clinical-practice recommendations for the management of bowel obstruction in patients with end-stage cancer, SUPP CARE C, 9(4), 2001, pp. 223-233
Authors:
De Conno, F
Ripamonti, C
Caraceni, A
Saita, L
Citation: F. De Conno et al., Palliative care at the National Cancer Institute of Milan, SUPP CARE C, 9(3), 2001, pp. 141-147
Authors:
Filiberti, A
Ripamonti, C
Totis, A
Ventafridda, V
De Conno, F
Contiero, P
Tamburini, M
Citation: A. Filiberti et al., Characteristics of terminal cancer patients who committed suicide during ahome palliative care program, J PAIN SYMP, 22(1), 2001, pp. 544-553
Authors:
Gnudi, S
Malavolta, N
Lisi, L
Ripamonti, C
Citation: S. Gnudi et al., Bone mineral density and bone loss measured at the radius to predict the risk of nonspinal osteoporotic fracture, J BONE MIN, 16(6), 2001, pp. 1130-1135
Authors:
Cherny, N
Ripamonti, C
Pereira, J
Davis, C
Fallon, M
McQuay, H
Mercadante, S
Pasternak, G
Ventafridda, V
Citation: N. Cherny et al., Strategies to manage the adverse effects of oral morphine: An evidence-based report, J CL ONCOL, 19(9), 2001, pp. 2542-2554
Authors:
Mercadante, S
Casuccio, A
Fulfaro, F
Groff, L
Boffi, R
Villari, P
Gebbia, V
Ripamonti, C
Citation: S. Mercadante et al., Switching from morphine to methadone to improve analgesia and tolerabilityin cancer patients: A prospective study, J CL ONCOL, 19(11), 2001, pp. 2898-2904
Authors:
Ripamonti, C
Gerbino, W
Citation: C. Ripamonti et W. Gerbino, Classical and inverted White's effects, PERCEPTION, 30(4), 2001, pp. 467-488
Authors:
Ripamonti, C
Panzeri, C
Groff, L
Galeazzi, G
Boffi, R
Citation: C. Ripamonti et al., The role of somatostatin and octreotide in bowel obstruction: Pre-clinicaland clinical results, TUMORI, 87(1), 2001, pp. 1-9
Authors:
Groff, L
Zecca, E
De Conno, F
Brunelli, C
Boffi, R
Panzeri, C
Cazzaniga, M
Ripamonti, C
Citation: L. Groff et al., The role of disodium pamidronate in the management of bone pain due to malignancy, PALLIAT MED, 15(4), 2001, pp. 297-307
Authors:
Ripamonti, C
Dickerson, ED
Citation: C. Ripamonti et Ed. Dickerson, Strategies for the treatment of cancer pain in the new millennium, DRUGS, 61(7), 2001, pp. 955-977
Authors:
Hanks, GW
de Conno, F
Cherny, N
Hanna, M
Kalso, E
McQuay, HJ
Mercadante, S
Meynadier, J
Poulain, P
Ripamonti, C
Radbruch, L
Casas, JRI
Sawe, J
Twycross, RG
Ventafridda, V
Citation: Gw. Hanks et al., Morphine and alternative opioids in cancer pain: the EAPC recommendations, BR J CANC, 84(5), 2001, pp. 587-593
Authors:
Giavaresi, G
De Terlizzi, F
Gnudi, S
Cadossi, R
Aldini, NN
Fini, M
Rocca, M
Ripamonti, C
Brandi, ML
Giardino, R
Citation: G. Giavaresi et al., Discriminant capacity of quantitative ultrasound versus dual x-ray absorptiometry to determine cancellous bone loss in ovariectomized rats, BONE, 26(3), 2000, pp. 297-303
Authors:
Westland, S
Ripamonti, C
Citation: S. Westland et C. Ripamonti, Invariant cone-excitation ratios may predict transparency, J OPT SOC A, 17(2), 2000, pp. 255-264
Authors:
Mercadante, S
Ripamonti, C
Casuccio, A
Zecca, E
Groff, L
Citation: S. Mercadante et al., Comparison of octreotide and hyoscine butylbromide in controlling gastrointestinal symptoms due to malignant inoperable bowel obstruction, SUPP CARE C, 8(3), 2000, pp. 188-191
Authors:
Gnudi, S
Ripamonti, C
Malavolta, N
Citation: S. Gnudi et al., Quantitative ultrasound and bone densitometry to evaluate the risk of nonspine fractures: A prospective study, OSTEOPOR IN, 11(6), 2000, pp. 518-523
Authors:
Ripamonti, C
Mercadante, S
Groff, L
Zecca, E
De Conno, F
Casuccio, A
Citation: C. Ripamonti et al., Role of octreotide, scopolamine butylbromide, and hydration in symptom control of patients with inoperable bowel obstruction and nasogastric tubes: Aprospective randomized trial, J PAIN SYMP, 19(1), 2000, pp. 23-34
Authors:
Ripamonti, C
Zecca, E
Brunelli, C
Groff, L
Boffi, R
Caraceni, A
Galeazzi, G
Martini, C
Panzeri, C
Saita, L
Viggiano, V
De Conno, F
Citation: C. Ripamonti et al., Pain experienced by patients hospitalized at the National Cancer Instituteof Milan: Research project "Towards a Pain-Free Hospital", TUMORI, 86(5), 2000, pp. 412-418
Authors:
Bruera, E
Ripamonti, C
Beattie-Palmer, L
Citation: E. Bruera et al., Use of trade names of drugs in abstracts from pain congresses, N ENG J MED, 343(11), 2000, pp. 818-818
Authors:
Ripamonti, C
Citation: C. Ripamonti, Management of dyspnea in advanced cancer patients, SUPP CARE C, 7(4), 1999, pp. 233-243
Authors:
Bianchi, M
Clavenna, A
Groff, L
Zecca, E
Ripamonti, C
Citation: M. Bianchi et al., Diclofenac does not modify methadone bioavailability in cancer patients, J PAIN SYMP, 17(4), 1999, pp. 227-229
Authors:
Malavolta, N
Zanardi, M
Veronesi, M
Ripamonti, C
Gnudi, S
Citation: N. Malavolta et al., Calcitriol and alendronate combination treatment in menopausal women with low bone mass, INT J TISS, 21(2), 1999, pp. 51-59
Authors:
Giavaresi, G
Fini, M
Gnudi, S
Mongiorgi, R
Ripamonti, C
Zati, A
Giardino, R
Citation: G. Giavaresi et al., The mechanical properties of fluoride-treated bone in the ovariectomized rat, CALCIF TIS, 65(3), 1999, pp. 237-241
Authors:
Ripamonti, C
Filiberti, A
Totis, A
De Conno, F
Tamburini, M
Citation: C. Ripamonti et al., Suicide among patients with cancer cared for at home by palliative-care teams, LANCET, 354(9193), 1999, pp. 1877-1878
Authors:
Gnudi, S
Ripamonti, C
Gualtieri, G
Malavolta, N
Citation: S. Gnudi et al., Geometry of proximal femur in the prediction of hip fracture in osteoporotic women, BR J RADIOL, 72(860), 1999, pp. 729-733